Blog · Peptide Therapy

BPC-157: The Peptide Changing How We Think About Healing

By Dr. Sogol Ash, NMD

If you've spent any time in wellness circles recently, you've likely heard BPC-157 mentioned alongside words like "regenerative," "gut repair," and "injury recovery." And unlike many supplements that cycle through biohacking culture and quietly disappear, BPC-157 has remained a fixture in clinical conversations — including my own practice — for good reason.

This guide is for anyone who's curious about BPC-157 but wants clinical context, not hype.

What Is BPC-157?

BPC-157 stands for Body Protection Compound-157. It is a synthetic peptide derived from a protein naturally found in human gastric juice. A peptide, in the simplest terms, is a short chain of amino acids — the building blocks of proteins. What makes BPC-157 notable is its range of studied effects on tissue repair, inflammation modulation, and gut barrier integrity.

Unlike pharmaceutical drugs that typically target a single receptor or pathway, BPC-157 appears to work through multiple mechanisms simultaneously, which is both what makes it clinically interesting and what makes self-directed use genuinely risky.

What Does BPC-157 Do?

The most well-established research on BPC-157 comes from preclinical studies, primarily in animal models. These have shown consistently strong signals in three areas: gut healing and barrier repair, musculoskeletal and tendon recovery, and systemic inflammation reduction.

In my clinical practice, I most commonly use BPC-157 for patients presenting with leaky gut (intestinal permeability), inflammatory bowel conditions, soft tissue injuries that aren't resolving through conventional approaches, and post-surgical recovery support. I also used it personally following a car accident three years ago, after chiropractic care and acupuncture failed to move the needle on my own musculoskeletal pain.

How Is BPC-157 Administered?

BPC-157 can be administered via subcutaneous injection, intramuscular injection, or orally. The route matters depending on the target area. For systemic gut healing, oral or subcutaneous is typically appropriate. For localized musculoskeletal issues — a specific tendon, joint, or injury site — injection closer to the affected area is generally preferred.

Dosing ranges vary depending on the patient's body weight, the condition being addressed, and whether BPC-157 is being used as a standalone therapy or as part of a broader protocol. This is precisely why I do not recommend sourcing or dosing this peptide independently. The research compounds available without a prescription are unregulated for purity and concentration, and the margin for error matters when we're working with peptides that have real biological activity.

Who Is a Good Candidate for BPC-157?

In my practice, I consider BPC-157 for patients who have confirmed gut permeability on functional lab testing such as a Gut Zoomer 3.0, patients with chronic soft tissue injuries that are not healing through standard physical therapy, those with inflammatory markers elevated on comprehensive labs, and patients recovering from surgery or significant physical trauma.

BPC-157 is generally well tolerated, but it is not appropriate for everyone. Patients with a personal or family history of certain cancers require careful evaluation before use, as some preclinical data suggests BPC-157 may have proliferative effects in specific tumor models. This is one of the most important reasons this peptide requires physician oversight.

What BPC-157 Is Not

BPC-157 is not a substitute for addressing the root causes driving inflammation or gut dysfunction. In my clinical protocol, I treat it as a powerful support tool within a broader framework — not as a standalone fix. If your gut is leaky because of unaddressed mold toxicity, SIBO, or a diet that's actively driving inflammation, adding BPC-157 will produce modest results at best. The order of operations matters.

It is also not FDA-approved for human use. This means no standardized manufacturing oversight, no guaranteed purity, and no formal safety data from large-scale human trials. That is not a reason to dismiss it — the preclinical literature is genuinely compelling — but it is a reason to be precise about sourcing and dosing, which requires working with a physician who understands the landscape.